m6A-Related Genes Contribute to Poor Prognosis of Hepatocellular Carcinoma

Table 1

Patient’s pathological feature and univariate analysis.

Characteristics		DFS			OS
		Month	value		Month	value
Age			0.23	1.34		0.20	1.66
≥65	63	38.55			45.64
<65	47	43.48			48.86
Gender			0.39	0.75		0.30	1.06
Male	60	37.56			44.79
Female	50	44.19			49.59
AFP (μg/L)			0.56	0.33		0.42	0.66
<20	56	44.38			50.14
≥20	54	37.65			44.50
HbsAg			0.56	0.35		0.37	0.80
Positive	73	39.93			46.45
Negative	37	42.02			48.11
Cirrhosis			0.39	0.73		0.29	1.13
Present	59	37.36			44.29
Absent	51	44.28			50.05
Tumor size			0.01	8.13		0.01	6.78
≥5 cm	57	35.37			42.00
<5 cm	53	45.88			51.98
Tumor number			0.01	9.60		0.01	10.57
Multiple	49	34.46			43.00
Solitary	61	44.38			49.28
Vascular invasion			0.01	7.94		0.01	8.69
Yes	42	30.45			37.86
No	68	46.80			52.58
Capsule			0.01	11.61		0.01	12.71
Absence	47	49.15			54.83
Presence	63	33.13			40.11
Distant metastasis			0.01	26.81		0.01	26.70
Absence	47	26.64			34.88
Presence	63	49.72			55.19
TNM stage			0.01	38.60		0.01	39.88
I	12	78.64			78.64
II	33	45.85			53.35
III	65	31.07			38.13
Model			0.01	37.78		0.01	41.41
High risk	64	28.09			35.69
Low risk	46	55.76			60.76